MAM
Automotive component manufacturers association of India
MUMBAI: Automotive Component Manufacturers Association of India (ACMA), the apex body representing India’s auto component manufacturing industry, today announced the appointment of Deepak Jain, Chairman & Managing Director, Lumax Industries Ltd. as its President and Sunjay Kapur, Chairman, Sona Comstar as the Vice President for the term 2019-21. The announcement was made at the 59th ACMA Annual Session of the Industry body.
Announcing the new President, ACMA Director General, Vinnie Mehta, said, “We are delighted to announce the appointment of Deepak Jain, as ACMA President. An industry veteran and a leading manufacturer of auto components & systems, Deepak has an in-depth understanding of industry dynamics. We look forward to his leadership in taking the industry’s agenda forward in these challenging times.”
Accepting the new responsibility, ACMA President, Deepak Jain, said, “It is a matter of privilege to be appointed as the President of ACMA, the apex body of the Indian Auto Component Industry. The industry is going through one of the most difficult times ever. Notwithstanding the regulations-led-technological changes and business cyclicality, the industry needs to prepare itself for the future. We have therefore created a new pillar at ACMA to focus exclusively on xEVs & Future Mobility. It is indeed an imperative for ACMA to drive change through the entire auto component manufacturing chain and help its members stay relevant to their customers. I am confident that we will well scale the challenges confronting us with the support of the government and all our stake holders.”
MAM
Beacon Group appoints Dr Rajesh Patel as Group CEO
36-year healthcare veteran to lead Beacon Diagnostics, Vector Biotek, Biogeny.
MUMBAI: A new chief, a fresh diagnosis and a sharper prescription for growth. Beacon Group has appointed Dr Rajesh Patel as its Group Chief Executive Officer, effective April 1, 2026, signalling a decisive push to scale its presence in the diagnostics and IVD space. Patel steps into the role with 36 years of experience across the healthcare and diagnostics industry, bringing a career shaped by leadership roles spanning sales, marketing, business development and operational strategy. His mandate is both expansive and precise: to steer the group’s overall strategic direction while tightening coordination across its three core entities Beacon Diagnostics, Vector Biotek and Biogeny Diagnostics.
In practical terms, that means driving cross-company synergies, accelerating market expansion and strengthening organisational capability areas increasingly critical as diagnostic players compete for scale in a fragmented yet rapidly evolving healthcare ecosystem. The group is positioning itself to capture unmet demand across chain laboratories, key accounts and standalone labs, segments that remain underserved despite growing diagnostic needs.
The appointment comes at a time when the In Vitro Diagnostics (IVD) sector in India is entering a more competitive and innovation-led phase, with companies focusing not just on product pipelines but also on service delivery, integration and customer-centric models. Beacon’s leadership appears to be betting that Patel’s execution-focused approach can help translate ambition into operational momentum.
Welcoming the appointment, Chairman Dr D K Joshi described Patel’s induction as a strategic move aligned with the group’s long-term vision, emphasising the role of leadership depth in navigating the next phase of growth.
For Beacon Group, the message is clear, in a sector where precision matters, leadership is the new differentiator—and this appointment is intended to set the tone for what comes next.
